BRILIQUE

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Lithuania, Netherlands, Poland, Romania, Spain, Tunisia, UK.

Active ingredients

The drug BRILIQUE contains one active pharmaceutical ingredient (API):

1	Ticagrelor UNII GLH0314RVC - TICAGRELOR
	Ticagrelor is an oral, direct acting, selective and reversibly binding P2Y12 receptor antagonist that prevents ADP-mediated P2Y12 dependent platelet activation and aggregation. Since platelets participate in the initiation and/or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function has been shown to reduce the risk of CV events such as death, MI or stroke.
	Read more about Ticagrelor

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BRILIQUE Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC24	Ticagrelor	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1506574, 1506585, 1506596, 1506608, 1506619, 1506620, 1712023, 1712034, 1712045, 1712067, 1712078, 1746828, 1746839, 1746840, 1787115
ES	Centro de información online de medicamentos de la AEMPS	10655004, 10655006, 110655009, 110655013
FI	Lääkealan turvallisuus- ja kehittämiskeskus	111840, 382207, 419730, 447047, 579515
FR	Base de données publique des médicaments	61958462, 64746646
GB	Medicines & Healthcare Products Regulatory Agency	182904, 299803, 324477, 346721, 374309, 376220, 379803, 381214, 399690
IE	Health Products Regulatory Authority	17964, 26100, 26102
LT	Valstybinė vaistų kontrolės tarnyba	1057918, 1057919, 1057920, 1057921, 1057922, 1057923, 1080255, 1080256, 1080257, 1080258, 1080259, 1083154, 1083155, 1083156
NL	Z-Index G-Standaard, PRK	130680, 167762, 97446
PL	Rejestru Produktów Leczniczych	100236165, 100370811, 100407709
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W56291001, W56291002, W56291003, W56291004, W56291005, W56291006, W62794001
TN	Direction de la Pharmacie et du Médicament	8233041